Fig. 4From: Bevacizumab plus erlotinib versus erlotinib alone for advanced EGFR-mutant non-small cell lung cancer: a meta-analysis of randomized clinical trialsFor patients with brain metastasis, forest plots of PFS (A) and OS (B) between combination therapy and monotherapyBack to article page